Search Menu

Rita Balice-Gordon

Rita Balice-Gordon, Ph.D., is the Global Head, Rare and Neurologic Diseases Research Therapeutic Area at Sanofi, Inc.  She leads groups of scientists based in Boston and Paris working on small molecules, antibodies and gene therapy as modalities for discovering and developing innovative and transformative therapeutics for patients …

Read more

Phil Skolnick

Dr. Skolnick is the Chief Scientific Officer at Opiant Pharmaceuticals, Inc. Prior to joining Opiant, he was the Director, Division of Therapeutics and Medical Consequences at the National Institute on Drug Abuse, NIH (2010-2017).  He served as Chief Scientific Officer (2001-2009) and President (2007-2009) of DOV Pharmaceutical, …

Read more

Replication Study: The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44

The Reproducibility Project: Cancer Biology aims to replicate a number of landmark studies in the field of tumor biology published between 2010 – 2012. The latest replication attempt was published on March 12thin eLIFE and focused on a publication from 2011 by Liu et al. The attempt to …

Read more

Valentina Vengeliene

Valentina obtained a PhD in pharmacology from Heidelberg University in 2005, based on her research done at the Central Institute of Mental Health in Mannheim, Germany. Following her PhD, she continued as a scientist at the Central Institute of Mental Health, focusing on addiction. In particular, …

Read more

Scroll Up